17 main street management corp.

315 5th avenue 5th floor
new york, new york 10016

NYS Entity Status
ACTIVE

NYS Filing Date
OCTOBER 30, 2002

NYS DOS ID#
2829089

County
WESTCHESTER

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC BUSINESS CORPORATION

Name History
2002 - 17 MAIN STREET MANAGEMENT CORP.









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • Near The East River, Plans Emerge For NY’s Next Life Science Center
    By Ben Fidler - Monday Aug 21, 2017

    At a time when biotech incubators and shared spaces are beginning to multiply in Manhattan, work on what could rank among the city’s largest biotech centers—if it can all come together—is just getting underway. According to Paul Wexler, a longtime healthcare-focused real estate broker, construction should begin next year on what is being called the […]

    Source: Xconomy New York
  • Harvey Techies Pass Baton, And APIs, To Florida Peers as Irma Nears
    By Angela Shah - Friday Sep 8, 2017

    Houston—As Tropical Storm Harvey made landfall in Houston, Florida resident Leah Halbina messaged friends in the city asking how she could help. That was how she found out about Sketch City and the various civic tech projects the group and others were developing to aid rescue efforts, help people find shelter, and tend to other […]

    Source: Xconomy New York
  • As Relief Moves to Recovery, Questions About FEMA’s Tech Corps
    By Angela Shah - Thursday Oct 5, 2017

    Houston—As Hurricane Harvey whirled toward the Texas Gulf Coast, a volunteer group of techies in Texas and other parts of the country gathered in a Slack channel to develop tools that could help with rescue, recovery, and relief efforts. Nearly six weeks later, that group of volunteers—with some coming in and some leaving—has continued its […]

    Source: Xconomy New York
  • Acorda Takes Another Hit, Reports Patient Deaths in Parkinson’s Study
    By Ben Fidler - Wednesday Nov 15, 2017

    Acorda Therapeutics’ rebuilding plan just suffered another setback, leaving the fate of one of the experimental Parkinson’s disease drugs that is closest to market unclear. Ardsley, NY-based Acorda (NASDAQ: ACOR) said Wednesday morning that it has seen troubling safety problems in a Phase 3 trial of its experimental Parkinson’s disease drug tozadenant. Acorda reported cases […]

    Source: Xconomy New York